Dexmethylphenidate extended-release is a prescription drug that is licensed to treat attention deficit hyperactivity disorder (ADHD). While the medicine is a stimulant, it produces a calming effect. In previous studies, dexmethylphenidate extended-release was shown to be effective at treating symptoms of ADHD in both children and adults. Headaches, throat pain, and dry mouth are a few of the common side effects with this medication.
What Is Dexmethylphenidate Extended-Release?
Dexmethylphenidate extended-release (Focalin XR®) is a prescription medication that is used for the treatment of attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate extended-release capsules are specially designed to release half of the medication immediately, and to release the second half of the medication after approximately four hours. As a result, dexmethylphenidate extended-release can be taken just once a day.
Because dexmethylphenidate extended-release is a stimulant and is commonly abused, there are special rules for prescribing the medication (see Focalin XR: A Controlled Substance).
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed December 8, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click